Andrew Last

BD Biosciences, Systems & Reagents, Inc. provides tools and solutions to research and clinical laboratories in basic research, drug discovery, development, biopharmaceutical production and disease management. The company was founded on May 9, 1991 and is headquartered in San Jose, CA.

Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million.

Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA.

CellChorus LLC is a company that applies artificial intelligence to visually evaluate the performance of individual immune cells such as T cells and NK cells over time. The company is based in South San Francisco, CA and was founded by Navin Varadarajan and Laurence James Neil Cooper. The company uses time-lapse imaging microscopy in nanowell grids (TIMING) with neural network-based AI to identify cells and evaluate their activity. The company's patent-protected platform can link TIMING data and insights with information from other analysis modalities to provide a comprehensive understanding of cellular function, state, and phenotype for the life sciences industry. CellChorus conducts dynamic single-cell analysis at scale and has been featured in various publications such as Blood, Leukemia, and Nature Immunology. Daniel Meyer has been the CEO of the company since 2020.